Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors

Insulin-like growth factors I and II (IGF-I and -II) are potent mitogens for various cancers, including carcinoma of the prostate. In several experimental cancers, treatment with antagonists of growth hormone-releasing hormone (GH-RH) produces a reduction in IGF-I and -II, concomitant to inhibition...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Lamharzi, Najib, Schally, Andrew V., Koppán, Miklós, Groot, Kate
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1998
Assuntos:	Biological Sciences
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC21168/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9671770/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.95.15.8864
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!